Life Sciences

Patient-oriented marketing fostered with innovative healthcare to patients, greater customer expectations , regulatory & financial constraints create unprecedented demands on the life sciences industry’s ability to deliver superior value to shareholders.

Rising R&D costs and drug patent expirations increases focus on cost cutting measures especially in processes which are not directly related to R&D such as- sales and marketing, procurement & supply chain. Hence, it gets essential for companies to leverage on their core competencies by collaborating across the extended enterprise to create higher values.

A major challenge within the life sciences is integration of IT infrastructure with the existing business processes and models. Lack of integration & transparency fosters adoption of complex silos based approach, thereby increasing cost & lack of visibility. Such an environment makes the business brittle & clumsy.

ATG’s ability to anticipate and adapt to change operationally as well as strategically both in short & long-terms can help companies in life science to transform a market or create a new one for them. Strike an ideal balance between intellectual property & resource consumption. Maximize the reuse of legacy assets & capture new markets with customized & affordable solutions at ATG.